AChE is an essential enzyme in cholinergic neurotransmission, and its reversible inhibition has a therapeutic relevance in several neurodegenerative disorders like Alzheimer’s disease (AD), myasthenia gravis, and glaucoma, among others [3]. Here, ACHE is linked to Alzheimer disease.